Opioid-Related Genetic Polymorphisms of Cytochrome P450 Enzymes after Total Joint Arthroplasty: A Focus on Drug-Drug-Gene Interaction with Commonly Coprescribed Medications.
Orthop Clin North Am
; 53(4): 361-375, 2022 Oct.
Article
em En
| MEDLINE
| ID: mdl-36208880
ABSTRACT
Pharmacogenomic testing, together with the early detection of drug-drug-gene interactions (DDGI) before initiating opioids, can improve the selection of dosage and reduce the risk of adverse drug interactions and therapeutic failures following Total Joint Arthroplasty. The variants of CYP genes can mediate DDGI. Orthopedic surgeons should become familiar with the genetic aspect of opioid use and abuse, as well as the influence of the patient genetic makeup in opioid selection and response, and polymorphic variants in pain modulation.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Polimorfismo Genético
/
Analgésicos Opioides
Tipo de estudo:
Screening_studies
Limite:
Humans
Idioma:
En
Revista:
Orthop Clin North Am
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Estados Unidos